UK Innovation & Science Seed Fund News

Cambridge, UK, 11 September 2018 – Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T-cell enhancing therapeutics, today announces that Pavel Pisa, MD, PhD, has been appointed as Chief Medical Officer of the Company with immediate effect. Pavel Pisa is the former Head of Translational Medicine at Roche and Genentech and has led […]

read more

Co-sell partnership to provide unparalleled access to Microsoft’s Enterprise customers Eagle Genomics solution enables assessment of viability, efficacy and safety of enterprise branded products Driving digital reinvention of life sciences using artificial intelligence to map the microbiome LONDON [date], Eagle Genomics joins a specialised group of high-growth startups, earning co-sell status as part of Microsoft’s […]

read more

Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program for glaucoma TOKYO, CAMBRIDGE (UK), August 10, 2018 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa,Ph.D., “Astellas”) and Quethera Limited (CEO: Peter Widdowson, Ph.D., “Quethera”) today announced that Astellas has acquired Quethera, a gene therapy company headquartered […]

read more

1 2 3 4 25